Which drugs does patent 5,935,946 protect, and when does it expire?
Patent 5,935,946 protects VIREAD, ATRIPLA, COMPLERA, STRIBILD, and TRUVADA, and is included in six NDAs. There have been zero Paragraph IV challenges on Truvada, Complera, Viread, and .
Protection for VIREAD has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty patent family members in twenty countries.